CorMedix is back in focus as analysts reset their price targets, with some moving to $16 from $20, others to $13 from $15, ...
Over the past ten days, I’ve watched probably 150 viral videos like this — cartoon food characters, rendered in brightly ...
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results